CUTAQUIG: payments to doctors
Payments that named CUTAQUIG as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $1.1M
- Providers
- 5,290
- Transactions
- 27,447
- Average per transaction
- $39
The per-transaction average — $39 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 5,290 providers the average total is $202, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Octapharma USA, Inc. | $661,800 | 61.9% |
| Pfizer | $370,470 | 34.7% |
| Hospira, Inc. | $35,677 | 3.3% |
| PBG Puerto RICO LLC | $648 | 0.1% |